论文部分内容阅读
目的 探讨喘乐宁及丙酸倍氯米松吸入对喘憋患儿的疗效观察。方法 1999年11月～2002年2月收住我院的喘憋为主要症状的毛细支气管交和肺炎患儿168例。随机分为两组,治疗组108例.对照组60例.治疗组于入院24小时内开始给予喘乐宁0.25ml加生理盐水3ml做气动雾化吸入,每天2次,每次10min;另外应用面罩型筒式储雾罐吸入丙酸倍氯米松,1日 2次,每次125μg。结果 治疗组与对照组总有效率分别为89.8％和51.7％有显著差异性(P<0.01)治疗5天复查胸片治疗组明显好转(P<0.05),平均住院天数明显缩短(t=5.736 P<0.05)。结论 喘乐宁及丙酸倍氯米松吸入治疗婴幼儿喘憋,疗效肯定,安全方便。
Objective To investigate the efficacy of inhaled salbutamol and beclomethasone dipropionate on asthmatic children. Methods From November 1999 to February 2002, 168 children with bronchiolitis and pneumonia, the main symptoms of wheezing in our hospital, were admitted to our hospital. Were randomly divided into two groups, the treatment group of 108 cases.The control group of 60. In the treatment group within 24 hours of admission to the beginning of given 0.25ml salbutamol saline plus 3ml aerosol inhalation, 2 times a day for 10min each; In addition Mask type cartridge mist inhaler beclometasone dipropionate, 2 times a day, each 125μg. Results The total effective rates of the treatment group and the control group were 89.8% and 51.7%, respectively (P <0.01). The treatment of the chest radiotherapy group was significantly improved (P <0.05) and the average length of hospital stay was significantly shorter (t = 5.736 P <0.05). Conclusion Astragalin and beclometasone dipropionate inhalation treatment of infantile asthma, positive effect, safe and convenient.